Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up

A. Lasagna, D. Lilleri, F. Agustoni, E. Percivalle, S. Borgetto, N. Alessio, G. Comolli, A. Sarasini, F. Bergami, J. C. Sammartino, A. Ferrari, F. Zavaglio, F. Arena, S. Secondino, M. Falzoni, R. Schiavo, G. Lo Cascio, L. Cavanna, F. Baldanti, P. PedrazzoliI. Cassaniti

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences